Is Your Pharma Website Delivering What Patients and HCPs Need? Strengthening Digital Experiences with UX Research

Executive Summary: As pharmaceutical brands compete for attention in increasingly complex digital environments, UX research is emerging as a key driver of more effective website experiences. This blog post examines how understanding real user behavior helps pharma organizations reduce friction, align content with patient and HCP needs and build stronger, more intuitive digital experiences that improve patient engagement, healthcare decision-making and outcomes.

Here is an uncomfortable truth for pharmaceutical brand teams building or refining digital experiences: your website may be working against you. Not because of regulatory missteps or weak content, but because the people you most need to reach—patients navigating a new diagnosis, caregivers overwhelmed by support decisions, healthcare professionals (HCPs) searching for clinical clarity—are leaving before they find what they came for. And most pharma organizations don’t know it’s happening.

This is where User Experience (UX) research changes everything.

UX research, the discipline of systematically studying how real users interact with a digital experience is not a luxury reserved for tech companies. It is one of the most underutilized competitive weapons in pharmaceutical marketing. And in an environment where a brand’s digital presence is often the first, and sometimes only, touchpoint between a therapy and the person who needs it, the stakes for patient education, HCP engagement and treatment support have never been higher.

Why Do Pharma Brand Websites Often Struggle to Meet Patient, Caregiver and HCP Needs?

Pharma brand websites are typically built by committee: medical, legal, regulatory, marketing and agency teams all leave their mark. The result is often a site that satisfies internal stakeholders but confuses the external audiences it was designed to serve.

Consider the numbers. Without a clear value proposition, users leave web pages within seconds. For a patient who just received a life-changing diagnosis, that window is even shorter—the cognitive load of illness leaves little patience for cluttered navigation or buried safety information.

And yet, the average pharma brand website experience is still organized around what the brand wants to say, not what the patient or HCP needs to find. Disease awareness content competes with dosing information. Important Safety Information (ISI) disclosures overwhelm without context. Patient support program details are buried three clicks deep.

UX research closes this gap by replacing assumptions with evidence. Evidence also needs to incorporate an understanding of why people behave the way they do. Escalent Group—Escalent, C Space, Hall & Partners—helps brands uncover the beliefs, motivations, emotions and contextual forces shaping patient, caregiver and HCP decision-making through a behavioral science-led approach. When combined with UX research, this deeper human understanding enables pharmaceutical brands to go beyond optimizing patient and HCP journeys to design more intuitive healthcare digital experiences centered around how people actually navigate health decisions in the real world.

“The most effective pharma digital experiences are designed around patient realities and HCP decision-making behaviors, not internal brand structures or assumptions about how users search for information.” —Robbi Shamlian, VP, Head of UX, C Space

Three Ways UX Research Improves Pharma Website Strategy and Digital Engagement

1. UX Research Uncovers How Patients and HCPs Search for and Understand Healthcare Information Online

Patients don’t think the way pharma brand teams do. A patient newly diagnosed with a chronic condition may not know the clinical name of their disease, let alone search for it by that term. UX research methods like card sorting, tree testing and moderated user interviews reveal how patients and caregivers mentally categorize information and the language they use. The result: navigation architectures and content hierarchies that map to real human cognition, not internal org charts.

This is also where broader audience understanding becomes critical. Escalent Group’s expertise in segmentation, audience deep dive and customer experience helps pharmaceutical brands understand not just how users search for information, but how different patient and HCP audiences interpret, prioritize, and act on that information. By combining UX research with behavioral science and audience insight, brands can create digital experiences that feel more relevant, intuitive and personally meaningful across the healthcare journey.

Our qualitative work across therapy areas consistently shows a striking disconnect between the terminology brand teams use and the words patients use when searching online, prompting AI tools or discussing aloud with healthcare providers. Bridging that language gap on your website is not just good UX, it is foundational to pharma brand relevance.

One recent example involved an oncology patient education website that was being restructured around the phases of the cancer journey, from diagnosis through treatment and living with cancer. The research began with concept testing to understand which narratives, imagery, and messages felt most relevant and intuitive to patients. It then moved into tree testing and follow-up interviews to identify where the site’s navigation, labels and content organization were creating confusion.

The findings led to a revised information architecture and updated language that better reflected how patients naturally understood and searched for oncology information. The research also revealed a strong desire for real patient stories and testimonials, informing a subsequent phase focused on capturing lived treatment experiences to make the site feel more credible, human and supportive.

2. UX Research Reduces Friction Across the Patient and HCP Journey

In pharma, friction is not merely frustrating, it can be clinically consequential. A caregiver who cannot find the patient assistance program application abandons the effort. An HCP who cannot quickly locate a prescribing guide defaults to a competitor they know better. UX research, particularly through usability testing with representative users, identifies precisely where these friction points occur and why.

The key insight: friction is rarely where brand teams expect it to be. It is almost never the safety information that derails a user journey. It is the unclear call-to-action on the homepage, the form that times out before a patient with limited digital literacy can complete it, the mobile experience that was never tested on Android devices that many Medicaid patients use. UX research makes the invisible visible.

3. UX Research Helps Pharma Teams Prioritize Digital Investments

One of the persistent challenges in pharmaceutical digital marketing is justifying investment in web experience improvements against a backdrop of competing priorities. UX research solves this problem by converting qualitative frustration into quantitative impact. Task completion rates, time-on-task metrics and error rates from usability studies give healthcare brand and digital teams the data they need to make the case and to prioritize the improvements that will move the needle most.

At Escalent Group, we see organizations that integrate UX research into their digital development process make faster, more confident decisions. They stop debating what users want in conference rooms and start building what users actually need, validated by evidence.

Why UX Research Is a Competitive Advantage for Pharmaceutical Brands

The competitive landscape for pharma digital experiences is intensifying. Direct-to-consumer (DTC) advertising is driving more patients and caregivers directly to brand websites. Formulary changes and payer complexity are pushing HCPs to seek digital resources they can trust. And the emergence of AI-powered health search tools means that the clarity, structure and discoverability of your web content now affect how your brand is surfaced in AI-generated answers, not just traditional search results.

Pharma brands that invest in user experience research now are building a durable advantage. They will know their users more deeply, serve them more effectively and earn the kind of trust that translates to stronger therapy initiation and adherence outcomes.

Brands that don’t will keep building websites for themselves.

Building Better Pharma Websites Through Continuous UX Research

UX research is not a one-time audit. It is a practice, an ongoing commitment to understanding the human beings using your digital experience and letting that understanding shape every decision. When UX research is embedded in your brand’s digital strategy, it becomes a force multiplier for everything else you invest in: your healthcare content strategy, your media spend, your patient support programs.

The brands that will win in pharmaceutical digital marketing over the next decade will not be those with the biggest budgets. They will be those with the deepest understanding of their users and the discipline to act on that understanding.

If you are ready to see your brand website through the eyes of the patients and HCPs you serve, Escalent Group can help. Our approach brings together UX research, behavioral science and brand strategy to uncover not only how users interact with digital experiences, but what drives their decisions. The result is a stronger digital pharma customer experience built on evidence, human understanding and insights that support both brand growth and better healthcare engagement.

Want to learn more? Let’s connect.